Drugmaker GlaxoSmithKline is bolstering scientific expertise on its board by establishing a new science committee  charged with overseeing research  as a new chief executive prepares to take over Incoming CEO Emma Walmsley  the first woman to lead a top global drugmaker  stands out among Big Pharma bosses as a consumer brands specialist rather than a prescription medicines expert